Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | LIPE | Q05469 | 1/20 | 0.39 |
| ▸ | SLC22A12 | Q96S37 | 7/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.39 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PARL | Q9H300 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CTSS | P25774 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4831923 | 0.87 | KMT2A (0.50) | KMT2AMEN1LIPESLC22A12CYP2C9 | |
| SCHEMBL547625 | 0.84 | KMT2A (0.46) | KMT2AMEN1LIPESLC22A12ALDH1A1 | |
| SCHEMBL29369448 | 0.84 | KMT2A (0.46) | KMT2AMEN1LIPESLC22A12ALDH1A1 | |
| SCHEMBL4361781 | 0.83 | KMT2A (0.45) | KMT2AMEN1LIPESLC22A12CYP2C9 | |
| SCHEMBL4334243 | 0.81 | KMT2A (0.43) | KMT2AMEN1LIPESLC22A12CYP2C9 | |
| SCHEMBL452741 | 0.81 | PARL (0.57) | KMT2AMEN1SLC22A12CYP2C9SLC22A6 | |
| SCHEMBL29369615 | 0.81 | PARL (0.57) | KMT2AMEN1SLC22A12CYP2C9SLC22A6 | |
| SCHEMBL2069720 | 0.79 | KMT2A (0.43) | KMT2AMEN1LIPESLC22A12CYP2C9 | |
| SCHEMBL29369870 | 0.79 | KMT2A (0.43) | KMT2AMEN1LIPESLC22A12CYP2C9 | |
| SCHEMBL29369802 | 0.78 | KDM4E (0.55) | KMT2AMEN1SLC22A12CYP2C9SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7374857-B2 | Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition | WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) | 2008-05-20 | — | — | US | disclosed |
| US-20050038261-A1 | Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition | WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) | 2005-02-17 | — | — | US | disclosed |
| EP-1449833-A1 | BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION | Wako Pure Chemical Industries, Ltd. (JP) | 2004-08-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038261-A1 | Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition | ASIC1, GAR1, RER1 | KMT2A 1016/4885MEN1 211/4885LIPE 3281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.